Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration

Annals of Surgical Oncology

Volumn 15, Issue 4, 2008, Pages 1025-1031

  Van Der Ploeg, Iris M C ^a   Kroon, Bin B R ^a   Antonini, Ninja ^a   Valdés Olmos, Renato A ^a   Rutgers, Emiel J T ^a   Nieweg, Omgo E ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Breast neoplasms; False negative reactions; Lymphatic metastasis; Recurrence; Sentinel lymph node biopsy

Indexed keywords

NANOCOLL TC 99M;

ADULT; AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CONFERENCE PAPER; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS;

EID: 40549107111     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9760-6     Document Type: Conference Paper

References (36)

1. Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 2006; 95:279-93
2. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006; 98:599-609
3. Schrenk P, Rieger R, Shamiyeh A, et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000; 88:608-14
4. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349:546-53
5. TNM Classification of malignant tumorurs. Sixth edition ed. 2002. New York: Wiley
6. Nieweg OE, van Rijk MC, Valdes Olmos RA, et al. Sentinel node biopsy and selective lymph node clearance-impact on regional control and survival in breast cancer and melanoma. Eur J Nucl Med Mol Imaging 2005; 32:631-4
7. Wright FC, Walker J, Law CH, et al. Outcomes after localized axillary node recurrence in breast cancer. Ann Surg Oncol 2003; 10:1054-8
8. Nieweg OE, Estourgie SH, Valdes Olmos RA, et al. Lymphatic mapping with tracer administration into the primary breast cancer. Eur J Surg Oncol 2003; 29:95-7
9. Estourgie SH, Nieweg OE, Valdes Olmos RA, et al. Lymphatic drainage patterns from the breast. Ann Surg 2004; 239:232-7
10. Paganelli G, Galimberti V, Trifiro G, et al. Internal mammary node lymphoscintigraphy and biopsy in breast cancer. Q J Nucl Med 2002; 46:138-44
11. Shen P, Glass EC, DiFronzo LA, et al. Dermal versus intraparenchymal lymphoscintigraphy of the breast. Ann Surg Oncol 2001; 8:241-8
12. van Rijk MC, Tanis PJ, Nieweg OE, et al. Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer. J Surg Oncol 2006; 94:281-6
13. Estourgie SH, Nieweg OE, Valdes Olmos RA, et al. Intratumoral versus intraparenchymal injection technique for lymphoscintigraphy in breast cancer. Clin Nucl Med 2003; 28:371-4
14. Estourgie SH, Tanis PJ, Nieweg OE, et al. Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol 2003; 10:935-41
15. van Rijk MC, Tanis PJ, Nieweg OE, et al. Sentinel node biopsy and concomitant probe-guided tumor excision of nonpalpable breast cancer. Ann Surg Oncol 2007; 14:627-32
16. Nieweg OE, Estourgie SH. What is a sentinel node and what is a false-negative sentinel node? Ann Surg Oncol 2004; 11:169S-173S
17. Krag DN. The Sentinel Node for Staging Breast Cancer: Current Review. Breast Cancer 1999; 6:233-6
18. Nieweg OE, Jansen L, Valdes Olmos RA, et al. Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med 1999; 26:S11-S16
19. de Boer R, Hillen HF, Roumen RM, et al. Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer. Br J Surg 2001; 88:118-22
20. Fredriksson I, Liljegren G, Arnesson LG, et al. Consequences of axillary recurrence after conservative breast surgery. Br J Surg 2002; 89:902-8
21. Recht A, Pierce SM, Abner A, et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1991; 9:988-96
22. Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 2004; 240:462-8
23. de Kanter AY, Menke-Pluymers MM, Wouters MW, et al. 5-Year follow-up of sentinel node negative breast cancer patients. Eur J Surg Oncol 2006; 32:282-6
24. Torrenga H, Fabry H, van der Sijp JR, et al. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis. J Surg Oncol 2004; 88:4-7
25. Domenech A. Patients with breast cancer and negative sentinel node biopsy without additional axillay dissection: evolution after a 5-year follow-up. Eur J Nucl Med Mol Imaging 33[Suppl 2], S155. 2006
26. Grigolato D. Imaging Axillary recurrence after sentinel node biopsy in primary breast cancer: accuracy in our clinical setting. Eur J Nucl Med Mol Imaging 33[Suppl 2], S271. 2006
27. Van Wely BJ. Fout negatieve sentinel lymph node biopsie; follow up van 391 sentinel lymph node negatieve patienten met borstkanker. Nederlandse Vereniging voor Heelkunde, Najaarsvergadering. 2006
28. Ruoslahti E. How cancer spreads. Sci Am 1996; 275:72-7
29. Estourgie SH, Nieweg OE, Valdes Olmos RA, et al. Eight false negative sentinel node procedures in breast cancer: what went wrong? Eur J Surg Oncol 2003; 29:336-40
30. de Kanter AY, van Geel AN, Paul MA, et al. Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control. Eur J Surg Oncol 2000; 26:652-6
31. Davidson NE, Morrow M, Kopans DB, et al. Case records of the Massachusetts General Hospital. Case 35-2005. A 56-year-old woman with breast cancer and isolated tumor cells in a sentinel lymph node. N Engl J Med 2005; 353:2177-85
32. Fant JS, Grant MD, Knox SM, et al. Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 2003; 10:126-30
33. Guenther JM, Hansen NM, DiFronzo LA, et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 2003; 138:52-6
34. van Rijk MC, Teertstra HJ, Peterse JL, et al. Ultrasonography and fine-needle aspiration cytology in the preoperative evaluation of melanoma patients eligible for sentinel node biopsy. Ann Surg Oncol 2006; 13:1511-6
35. Gallegos Hernandez JF, Tanis PJ, Deurloo EE, et al. Radio-guided surgery improves outcome of therapeutic excision in non-palpable invasive breast cancer. Nucl Med Commun 2004; 25:227-32
36. van der Ent FW, Kengen RA, van der Pol HA, et al. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 2001; 234:79-84